[go: up one dir, main page]

UA92467C2 - Гидрохлорид 4-[[4-[[4-(2-цианоэтенил)-2,6-диметилфенил]амино]-2-пиримидинил]амино]бензонитрила - Google Patents

Гидрохлорид 4-[[4-[[4-(2-цианоэтенил)-2,6-диметилфенил]амино]-2-пиримидинил]амино]бензонитрила

Info

Publication number
UA92467C2
UA92467C2 UAA200701971A UAA200701971A UA92467C2 UA 92467 C2 UA92467 C2 UA 92467C2 UA A200701971 A UAA200701971 A UA A200701971A UA A200701971 A UAA200701971 A UA A200701971A UA 92467 C2 UA92467 C2 UA 92467C2
Authority
UA
Ukraine
Prior art keywords
amino
cyanoethenyl
benzonitrile
dimethylphenyl
pyrimidinyl
Prior art date
Application number
UAA200701971A
Other languages
English (en)
Ukrainian (uk)
Inventor
Поль Теодоор Агнес Стевенс
Йозеф Пеетерс
Роже Петрус Гереберн Вандекрюйс
Алекс Герман Копманс
Original Assignee
Янссен Фармацевтика Н.В.
Тіботек Фармасьютікелз Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from MYPI20043578A external-priority patent/MY169670A/en
Application filed by Янссен Фармацевтика Н.В., Тіботек Фармасьютікелз Лтд. filed Critical Янссен Фармацевтика Н.В.
Publication of UA92467C2 publication Critical patent/UA92467C2/ru

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Изобретение касается фармацевтической композиции, которая содержит как активный ингредиент соль соляной кислоты и 4-[[4-[[4-(2-цианоэтенил)-2,6-диметилфенил]амино]-2-пиримидинил]амино]бензонитрила, и способа ее получения.
UAA200701971A 2004-09-02 2005-09-02 Гидрохлорид 4-[[4-[[4-(2-цианоэтенил)-2,6-диметилфенил]амино]-2-пиримидинил]амино]бензонитрила UA92467C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20043578A MY169670A (en) 2003-09-03 2004-09-02 Combinations of a pyrimidine containing nnrti with rt inhibitors

Publications (1)

Publication Number Publication Date
UA92467C2 true UA92467C2 (ru) 2010-11-10

Family

ID=38137294

Family Applications (2)

Application Number Title Priority Date Filing Date
UAA200702178A UA92469C2 (en) 2004-09-02 2005-09-02 Fumarate of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl amino benzonitrile
UAA200701971A UA92467C2 (ru) 2004-09-02 2005-09-02 Гидрохлорид 4-[[4-[[4-(2-цианоэтенил)-2,6-диметилфенил]амино]-2-пиримидинил]амино]бензонитрила

Family Applications Before (1)

Application Number Title Priority Date Filing Date
UAA200702178A UA92469C2 (en) 2004-09-02 2005-09-02 Fumarate of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl amino benzonitrile

Country Status (6)

Country Link
CN (2) CN101068597B (ru)
AP (1) AP2296A (ru)
CR (1) CR9031A (ru)
SG (1) SG155885A1 (ru)
UA (2) UA92469C2 (ru)
ZA (1) ZA200701826B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013170421A1 (zh) * 2012-05-14 2013-11-21 上海迪赛诺药业有限公司 利匹韦林盐酸盐醇化物多晶型物及其制备方法
CN103420920B (zh) * 2012-05-14 2016-04-27 上海迪赛诺药业有限公司 利匹韦林盐酸盐醇化物多晶型物及其制备方法
US11065198B2 (en) * 2016-10-24 2021-07-20 Janssen Sciences Ireland Unlimited Company Dispersible compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3429B1 (ar) * 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
MY169670A (en) * 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
ES2422196T3 (es) * 2002-08-09 2013-09-09 Janssen Pharmaceutica Nv Procesos para la preparación de 4-4-4-(2-cianoetenil)-2,6-dimetilfenil)amino)-2-pirimidinil)aminobenzonitrilo

Also Published As

Publication number Publication date
CN101068597A (zh) 2007-11-07
AP2007003934A0 (en) 2007-04-30
AP2296A (en) 2011-10-31
SG155885A1 (en) 2009-10-29
CR9031A (es) 2009-01-16
UA92469C2 (en) 2010-11-10
ZA200701826B (en) 2008-07-30
CN101056673A (zh) 2007-10-17
CN101068597B (zh) 2012-04-18

Similar Documents

Publication Publication Date Title
IL181650A0 (en) Hydrochloride of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
PL373679A1 (en) Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
NO2014032I1 (no) (E)-4-[[4-[[4-(2-cyanoetenyl)-2,6-dimetylfenyl-amino]--2-pyrfmidinyl]-amino]-benzonitril Rilpivirine) samt enhver terapeutisk ekvivalent form derav som er beskyttet av det aktuelle patentet så som farmasøytisk akseptable salter innbefattende hydrokloridsaltet av Rilpiverine; tenofovir og spesielt tenofovirdisproksilfumatat og emtricitabine.
WO2005037824A3 (de) Verfahren zur herstellung von aminocrotonylverbindungen
WO2009007441A3 (en) Crystalline form of (e) 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2 pyrimidinyl]amino]benzonitrile
JO2973B1 (en) Fumarate salt for (alpha-beta-R) -6-bromo-alpha-[2- (methylamino) ethyl-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinoline ethanol
EP1630157A4 (en) ANTAGONIST OF CASR
PL1632232T6 (pl) Sól 4-[[4-[[4-(2-cyjanoetenylo)-2,6-dimetylofenylo]amino]-2-pirymidynylo]amino]benzonitrylu
UA92467C2 (ru) Гидрохлорид 4-[[4-[[4-(2-цианоэтенил)-2,6-диметилфенил]амино]-2-пиримидинил]амино]бензонитрила
IL181649A0 (en) Furamate of 4-((4-((4-(2-cyanoethenyl)-2,6-dimethylphenyl)amino)-2-pyrimidinyl)amino) benzonitrile
AP2487A (en) Fumarate of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]-amino]-2-pyrimidinyl]amino]benzonitrile
HRP20110563T1 (en) Salt of 4[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile